Symbol
RGEN on Nasdaq
Investment type
Equity / COMMON STOCK
Latest Disclosed Shares Owned
4,599,860 shares
Security Ownership %
8.2%
Shares, Excluding Options vs Price
Value, Excluding Options

T. Rowe Price Associates, Inc. ownership in REPLIGEN CORP COMMON STOCK (RGEN)

17 Feb 2026 - T. Rowe Price Associates, Inc. has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 4,599,860 shares of REPLIGEN CORP COMMON STOCK (RGEN). This represents 8.2% ownership of the company. In their previous filing dated 08 Sep 2025, PRICE T ROWE ASSOCIATES INC /MD/ had reported owning 3,429,547 shares, indicating an increase of +34%. .
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.